Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 4

Peripheral Exudative Hemorrhagic Chorioretinopathy: Clinical Course Following Intravitreal Afl ibercept Treatment

Periferik Eksüdatif Hemorajik Koryoretinopati: İntravitreal Afl ibersept Tedavisi Sonrası Klinik Seyir

Pages
362–367
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We hereby report a patient with PEHC involving the fovea, demonstrate two-year clinical course following intravitreal afl ibercept injection and discuss treatment alternatives of this rare entity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Peripheral exudative hemorrhagic chorioretinopathy (PEHC) is a rare degenerative disorder of peripheral retina simulating choroidal melanoma and usually characterized by hemorrhages and exudation.
📊
Key Findings & Data:It is predominantly the disease of elderly hypertensive women and usually regress spontaneously with a resultant fi brotic scar.
💡
Conclusion & Impact:We hereby report a patient with PEHC involving the fovea, demonstrate two-year clinical course following intravitreal afl ibercept injection and discuss treatment alternatives of this rare entity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Peripheral exudative hemorrhagic chorioretinopathy (PEHC) is a rare degenerative disorder of peripheral retina simulating choroidal melanoma and usually characterized by hemorrhages and exudation. It is predominantly the disease of elderly hypertensive women and usually regress spontaneously with a resultant fi brotic scar. Treatment is necessary if the disease is extending or involving the fovea. We hereby report a patient with PEHC involving the fovea, demonstrate two-year clinical course following intravitreal afl ibercept injection and discuss treatment alternatives of this rare entity.

Özet

Periferik eksüdatif hemorajik koryoretinopati (PEHK) koroid melanomu ile karıştırılabilen, periferik retinada kanama ve eksüdasyonla karakterize nadir görülen bir dejeneratif hastalıktır. Sıklıkla ileri yaştaki hipertansif kadınların hastalığıdır ve genellikle kendiliğinden gerileyerek fi brotik bir skara dönüşür. Hastalık foveaya uzanıyorsa veya foveayı içeriyorsa tedavi gerektirir. Bu yazıda fovea uzanımı olan bir PEHK olgusunda afl ibersept tedavisi sonrası iki yıllık klinik seyir sunulmakta ve bu nadir hastalığın tedavi alternatifl eri tartı- şılmaktadır.

🔖

Cite This Article

ŞEKEROĞLU, M. A., DOĞUİZİ, S., YILMAZBAŞ, P. (2018). Peripheral Exudative Hemorrhagic Chorioretinopathy: Clinical Course Following Intravitreal Afl ibercept Treatment. Retina-Vitreus, Cilt: 27 - Sayı: 4, 362–367. https://ajindex.com/articles/308125

References (12)

  1. Mantel I, Uffer S, Zografos L. Peripheral exudative hemorrhagic chorioretinopathy: A clinical, angiographic, and histologic study. Am J Ophthalmol 2009;148:932-8
  2. Ghassemi F, Bazvand F, Hosseini SS. Pseudomelanoma at a referral center in Iran. J Ophthalmic Vis Res 2014;9:50-3
  3. Shields CL, Salazar PF, Mashayekhi A, Shields JA. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology.2009;116:529-35
  4. Kim YT, Kang SW, Lee JH, Chung SE. Peripheral exudative hemorrhagic chorioretinopathy in Korean patients. Jpn J Ophthalmol 2010;54:227-31
  5. Mashayekhi A, Shields CL, Shields JA. Peripheral exudative hemorrhagic chorioretinopathy: A variant of polypoidal choroidal vasculopathy? J Ophthalmic Vis Res 2013;8:264-7
  6. Pinarci EY, Kilic I, Bayar SA, Sizmaz S, Akkoyun I, Yilmaz G. Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy. Eye (Lond) 2013;27:111-2.
  7. Rishi P, Das A, Sarate P, Rishi E. Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation. Indian J Ophthalmol 2012;60:60-3
  8. Cebeci Z, Dere Y, Bayraktar Ş, Tuncer S, Kır N. Clinical Features and Course of Patients with Peripheral Exudative Hemorrhagic Chorioretinopathy. Turk J Ophthalmol 2016;46:215-20
  9. Takayama K, Enoki T, Kojima T, Ishikawa S, Takeuchi M. Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab. Clin Ophthalmol 2012;6:865-9
  10. Mantel I, Schalenbourg A, Zografos L. Peripheral exudative hemorrhagic chorioretinopathy: Polypoidal choroidal vasculopathy and hemodynamic modifi cations. Am J Ophthalmol 2012;153:910-22
  11. Goldman DR, Freund KB, McCannel CA, Sarraf D. Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: A report of 10 eyes. Retina 2013;33:48-55
  12. Alforja MS, Sabater N, Giralt J, Adán A, Pelegrín L, Casaroli- Marano R. Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy. Jpn J Ophthalmol 2011;55:425-7